Funding for this research was provided by:
Shire, part of Takeda (IIR-CAN-001615)
Text and Data Mining valid from 2019-05-27
Received: 7 March 2019
Accepted: 22 May 2019
First Online: 27 May 2019
Ethics approval and consent to participate
: The local ethical review board (Comité d’éthique de la recherche, CHU de Québec-Université Laval) granted ethical approval to carry out the study involving blood donations (file no. 2018-3857). All study subjects gave written informed consent.
: Not applicable.
: FM. served as a consultant and received research funds from for Pharvaris B.V., outside the submitted work. G.E.R. has been a member of advisory boards (Baxalta, Bayer, Biogen Idec, CSL Berhing, Novo Nordisk, Octapharma, Pfizer) and received funding from Bayer, CSL Behring and Pfizer (unrelated to the submitted work). J.H. has been a speaker/teacher for CLS Behring, Novartis, Shire and Aralez; he has been a member of advisory committees (AstraZeneca, CLS Behring, Shire, and Novartis) and a clinical investigator for Circassia, Merck (ALK), Stallergene, Boehringer-Ingelheim, GlaxoSmithKline (GSK), Teva, Novartis, Sanofi, AstraZeneca, Johnson & Johnson, CLS Behring, Shire, Roche, Green Cross and Griffols (unrelated to the submitted work).